Cargando…
[(18)F]AV‐1451 PET in behavioral variant frontotemporal dementia due to MAPT mutation
The validation of tau radioligands could improve the diagnosis of frontotemporal lobar degeneration and the assessment of disease‐modifying therapies. Here, we demonstrate that binding of the tau radioligand [(18)F]AV‐1451 was significantly abnormal in both magnitude and distribution in a patient wi...
Autores principales: | Bevan Jones, W. Richard, Cope, Thomas E., Passamonti, Luca, Fryer, Tim D., Hong, Young T., Aigbirhio, Franklin, Kril, Jillian J., Forrest, Shelley L., Allinson, Kieren, Coles, Jonathan P., Simon Jones, P., Spillantini, Maria G., Hodges, John R., O'Brien, John T., Rowe, James B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5224822/ https://www.ncbi.nlm.nih.gov/pubmed/28097206 http://dx.doi.org/10.1002/acn3.366 |
Ejemplares similares
-
[(18)F]AV‐1451 binding is increased in frontotemporal dementia due to C9orf72 expansion
por: Bevan‐Jones, Richard W., et al.
Publicado: (2018) -
[(18)F]AV-1451 binding in vivo mirrors the expected distribution of TDP-43 pathology in the semantic variant of primary progressive aphasia
por: Bevan-Jones, W R, et al.
Publicado: (2018) -
(18)F-AV-1451 positron emission tomography in Alzheimer’s disease and progressive supranuclear palsy
por: Passamonti, Luca, et al.
Publicado: (2017) -
(18)F-AV1451 PET imaging and multimodal MRI changes in progressive supranuclear palsy
por: Nicastro, Nicolas, et al.
Publicado: (2019) -
In vivo evidence for pre‐symptomatic neuroinflammation in a MAPT mutation carrier
por: Bevan‐Jones, W. Richard, et al.
Publicado: (2019)